Uh-oh, looks like you've been reading the liars on
Post# of 72447
(Total Views: 325)
Posted On: 10/07/2017 8:38:03 PM
Uh-oh, looks like you've been reading the liars on lieHUB and have let them convince you that things were said that were in fact NOT said.
Where does the company ever refer to Brilacidin as a "franchise drug"? What does that even mean?
Here's what I think makes sense (and of course this is just in my opinion):
Brilacidin has shown so far to be an incredibly powerful drug with few side effects. It's not absorbed significantly in the body when used for ulcerative proctitis. It has both antibiotic and anti-inflammatory properties. There are 3 clinical trials for 3 very different applications, all of which have been successful thus far.
Now: if you were a big pharma, would you want to buy the rights to market Brilacidin for Oral Mucositis, in its oral rinse form -- knowing that at some time some other company might buy the rights for Brilacidin oral rinse for dental infection? NO you would not. People might then buy that and use it off-label for oral mucositis.
That's just an example. A company would have to be crazy to license this drug for ONE use, knowing that other delivery platforms might be developed for other diseases, but might be used off-label for the use you licensed. What if it turns out that intravenous Brilacidin stops oral mucositis AND other side effects of chemo? (that's an example which I think is totally UNlikely -- just given as a "what if." )
You've seen the TV ads for all kinds of drugs. What big pharma would want to take out a TV ad for Brilacidin-OM, knowing that their competitor was marketing Brilacidin-UP? Answer: no one.
So, I do not think that a big pharma would want to make a deal for just one version of Brilacidin for one disease. And I don't think Leo would want to do that, because he knows that it would hurt the chances of licensing it for other things. I find it difficult to believe that there can be anything but a licensing of ALL forms of Brilacidin, to one company.
Leo has stated that he wants IPIX to be a ROYALTY company. Despite whatever scare tactics the bashers are trying to spew out, there is NO way that Leo is going to outright-sell Brilacidin. That would be stupid thing to do, unless someone bought the whole company. Leo is far from stupid, and he is the largest shareholder in the company. The most likely deal would be an upfront payment, and then ROYALTIES (probably 10-20%) on the sales of Brilacidin products. This would include ALL forms of Brilacidin, so if some other use comes up that we don't know about now, we'd still get royalties.
Do not believe the lies that those jerks are cranking out. They have spent the past couple of years suppressing the price, and screaming "Leo, make a deal, any deal" (that's an exact quote from one of them). Why do they want him to make a crappy deal? Because that's what the people behind the attack on the company want.... in my opinion.
Leo is NOT going to be a sucker and take some crap deal. He knows that Brilacidin is worth a huge amount, and he's going to get a good deal for the company. THAT'S why he did the shelf registration -- if some company wants to keep holding out for a deal that would cheat us, Leo's not going to take it. We'll just keep developing the drugs ourselves.
Where does the company ever refer to Brilacidin as a "franchise drug"? What does that even mean?
Here's what I think makes sense (and of course this is just in my opinion):
Brilacidin has shown so far to be an incredibly powerful drug with few side effects. It's not absorbed significantly in the body when used for ulcerative proctitis. It has both antibiotic and anti-inflammatory properties. There are 3 clinical trials for 3 very different applications, all of which have been successful thus far.
Now: if you were a big pharma, would you want to buy the rights to market Brilacidin for Oral Mucositis, in its oral rinse form -- knowing that at some time some other company might buy the rights for Brilacidin oral rinse for dental infection? NO you would not. People might then buy that and use it off-label for oral mucositis.
That's just an example. A company would have to be crazy to license this drug for ONE use, knowing that other delivery platforms might be developed for other diseases, but might be used off-label for the use you licensed. What if it turns out that intravenous Brilacidin stops oral mucositis AND other side effects of chemo? (that's an example which I think is totally UNlikely -- just given as a "what if." )
You've seen the TV ads for all kinds of drugs. What big pharma would want to take out a TV ad for Brilacidin-OM, knowing that their competitor was marketing Brilacidin-UP? Answer: no one.
So, I do not think that a big pharma would want to make a deal for just one version of Brilacidin for one disease. And I don't think Leo would want to do that, because he knows that it would hurt the chances of licensing it for other things. I find it difficult to believe that there can be anything but a licensing of ALL forms of Brilacidin, to one company.
Leo has stated that he wants IPIX to be a ROYALTY company. Despite whatever scare tactics the bashers are trying to spew out, there is NO way that Leo is going to outright-sell Brilacidin. That would be stupid thing to do, unless someone bought the whole company. Leo is far from stupid, and he is the largest shareholder in the company. The most likely deal would be an upfront payment, and then ROYALTIES (probably 10-20%) on the sales of Brilacidin products. This would include ALL forms of Brilacidin, so if some other use comes up that we don't know about now, we'd still get royalties.
Do not believe the lies that those jerks are cranking out. They have spent the past couple of years suppressing the price, and screaming "Leo, make a deal, any deal" (that's an exact quote from one of them). Why do they want him to make a crappy deal? Because that's what the people behind the attack on the company want.... in my opinion.
Leo is NOT going to be a sucker and take some crap deal. He knows that Brilacidin is worth a huge amount, and he's going to get a good deal for the company. THAT'S why he did the shelf registration -- if some company wants to keep holding out for a deal that would cheat us, Leo's not going to take it. We'll just keep developing the drugs ourselves.
(7)
(0)